Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
The excellent results for monoclonal antibodies in the treatment of severe uncontrolled asthma (SUCA) represent a milestone in current treatment of asthmatic disorders. Remaining, however, are several subsidiary areas for improvement in which new biologics are expected to make a decisive contributio...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-04-01
|
| Series: | Open Respiratory Archives |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2659663622000777 |